Reported about 2 months ago
Johnson & Johnson announced that it will purchase medical device manufacturer V-Wave for up to $1.7 billion, with an initial payment of $600 million and potential additional payments based on regulatory and commercial goals. This acquisition aims to boost J&J's growth as it prepares for increased competition after its Stelara medication loses patent protection. The V-Wave device, designed to be implanted in the heart to alleviate heart failure, is not yet approved for use in the U.S.
Source: YAHOO